Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices 3155 

in the examination center primarily via 

ACASI. 

The biospecimens collected for 

laboratory testing include urine and 

blood. Serum, plasma, and urine 

specimens are stored for future testing, 

including genetic studies, if the 

participant consents. Consent to store 

DNA will continue in NHANES. 

In 2021–22, we plan to add the 

following laboratory tests: Serum 

Terpenes: a-Pinene, b-Pinene, bMyrcene, D-3-Carene, Limonene, bCaryophyllene, a-Humulene; 

Magnesium; HPV, serum; Alpha-1-acidglycoprotein (AGP); Vitamin D; Vitamin 

A; Vitamin C; Acrylonitrile; Trans-fatty 

Acids; Blood butyrylcholinesterase 

activity, blood butyrylcholinesterase 

concentration, and red blood cell 

acetylcholinesterase activity; 

Enterovirus D68; and COVID–19 

serology. 

In 2021–22, the following laboratory 

tests will be modified: Hepatitis D (new 

testing method, reportable findings); Sex 

steroid hormone panel (now starting at 

3+); Urine VOC metabolites (adding as 

additional 7); trans, trans-Muconic acid; 

N-Acetyl-S-phenyl-L-cysteine; N–2- 

Furoylglycine; 2,5-Furandicarboxylic 

acid; 5-Hydroxymethyl-2- 

furancarboxylic acid; 5-Hydroxymethyl2-furoylglycine; and 5-Hydroxy-Nmethyl-2-pyrrolidone. 

The laboratory tests cycling out for 

2021–22 include: HPV swabs (male and 

female); HPV oral rinse; Home water 

sample collection to test for fluoride; 

Salt home collection for iodine 

assessment; Chromium/Cobalt; 

Tuberculosis (TB); and Urine flow rate. 

NHANES plans to conduct a dress 

rehearsal prior to fielding the survey as 

usual. This will be conducted in two 

locations, among a sample of 

approximately 300 volunteers per 

location (approximately 600 total). The 

program is taking this step to assure it 

maintains the consistent quality 

associated with data collection, given 

the necessary pause in field operations 

in 2020. The data collected during dress 

rehearsal will be used for quality control 

and training purposes. Dress rehearsal 

data will not be part of the 2021–22 

public release. 

NHANES plans to conduct 

developmental projects during NHANES 

2021–22 with a focus on planning for 

NHANES 2023 and beyond. These may 

include activities such as tests of new 

equipment, crossover studies between 

current and proposed methods, test of 

different study modes, settings, or 

technology, outreach materials, 

incentive strategies, sample storage and 

processing, or sample designs. 

Burden for individuals varies based 

on their level of participation. For 

example, infants and children tend to 

have shorter interviews and exams than 

adults because young people may have 

fewer health conditions or medications 

to report, certain exams are only 

conducted on individuals 18 and older, 

etc. In addition, adults often serve as 

proxy respondents for young people in 

their families. 

Participation in NHANES is voluntary 

and confidential. There is no cost to 

respondents other than their time. CDC 

requests a three-year approval, with 

65,630 annualized hours of burden. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Individuals in households ................................ Screener ......................................................... 8,300 1 10/60 

Individuals in households ................................ Household Interview ....................................... 5,600 1 1 

Individuals in households ................................ MEC Interview & Examination ....................... 5,600 1 2.5 

Individuals in households ................................ Day 1 and Day 2 Telephone Dietary Recall 

& Dietary Supplements.

5,600 1 1.3 

Individuals in households ................................ Flexible Consumer Behavior Survey Phone 

Follow-Up.

5,600 1 20/60 

Individuals in households ................................ Developmental Projects & Special Studies ... 3,500 1 3 

Individuals in households ................................ 24-hour wearable device projects .................. 1,000 1 25 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–00691 Filed 1–13–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). This meeting is open to the 

public, limited only by audio phone 

lines available. The public is also 

welcome to listen to the meeting by 

dialing 1–877–924–1748, passcode: 

3380216. A total of 200 lines will be 

available. Registration is required. To 

register for this call, please go to 

www.cdc.gov/hicpac. 

DATES: The meeting will be held on 

March 4, 2021, from 9 a.m. to 3 p.m., 

EST. 

ADDRESSES: The teleconference access is 

1–877–924–1748, and the passcode is 

3380216. 

FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC, 

Division of Healthcare Quality 

Promotion, NCEZID, CDC, 1600 Clifton 

Road NE, Mailstop H16–3, Atlanta, 

Georgia 30329–4027, Telephone (404) 

498–0730; Email: HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 


khammond on DSKJM1Z7X2PROD with NOTICES
3156 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include the following updates: The 

Healthcare Personnel Guideline 

Workgroup; the Long-term Care/Postacute Care Workgroup; the Neonatal 

Intensive Care Unit Workgroup; and 

updates from DHQP including DHQP’s 

engagement on Coronavirus disease 

response. Agenda items are subject to 

change as priorities dictate. 

Procedures for Public Comment: Time 

will be available for public comment. 

Members of the public who wish to 

provide public comments should plan 

to attend the public comment session at 

the start time listed. Please note that the 

public comment period may end before 

the time indicated, following the last 

call for comments. 

Procedures for Written Comment: The 

public may submit written comments in 

advance of the meeting. Comments 

should be submitted in writing by email 

to the contact person listed above. The 

deadline for receipt of written public 

comment is February 25, 2021. All 

requests must contain the name, 

address, and organizational affiliation of 

the speaker, as well as the topic being 

addressed. Written comments should 

not exceed one single-spaced typed page 

in length. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–00603 Filed 1–13–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1278] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Online Training 

for Law Enforcement to Reduce Risks 

Associated with Shift Work and Long 

Work Hours to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on October 1, 

2020 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function. Direct written comments and/ 

or suggestions regarding the items 

contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Online training for law enforcement 

to reduce risks associated with shift 

work and long work hours— 

Reinstatement without Change— 

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Police often work during the evening, 

at night, and sometimes irregular and 

long hours. Shift work and long work 

hours are linked to many health and 

safety risks due to disturbances to sleep 

and circadian rhythms. These work 

schedules also lead to difficulties with 

personal relationships due to having 

less time with family and friends, poor 

mood from sleep deprivation, and 

problems balancing work and personal 

responsibilities. These work schedules 

and inadequate sleep likely contribute 

to health problems seen in police: 

Shorter life spans, high occupational 

injury rates, and burden of chronic 

illnesses. One strategy to reduce these 

risks is training programs to inform 

employers and law enforcement officers 

about the risks and strategies to reduce 

their risks. 

An Reinstatement is being requested 

due to delays recruiting participants and 

initiating data. The delays resulted from 

the COVID–19 pandemic and the civil 

unrest after George Floyd’s death on 

May 25 2020. Law enforcement leaders 

requested that the data collection be 

delayed until the end of June 2020. As 

a result, NIOSH is requesting a one-year 

extension of the data collection end date 

to May 31, 2021. This pilot study is part 

of a project awarded National 

Occupational Research Agenda (NORA) 

funding. The National Institute for 

Occupational Safety and Health is 

authorized to carry out this data 

collection through Occupational Safety 

and Health Act of 1970. 

The purpose of this project is to 

develop a training program to relay the 

risks linked to shift work and long work 

hours and give workplace strategies for 

employers and personal strategies for 

the officers to reduce the risks. Once 

finalized, the training will be available 

on the NIOSH website. The training will 

be pilot tested with 30 recent graduates 

of a police academy and 30 experienced 

officers. The study will recruit 60 law 

enforcement officers during a 30-minute 

phone call. All respondents will work 

full-time on fixed night shifts. The pilot 

test will use a pre-test–post-test design 

to examine sleep (both duration and 

quality), worktime sleepiness, and 

knowledge retained. Pre-test measures 

will be collected two weeks before the 


khammond on DSKJM1Z7X2PROD with NOTICES